Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{187696,
        author = {Miss. Shivani P. Pandit and Mr. Akshay R. Gadhari},
        title = {Formulation And Evalution Of Diltiazem Hydrochloride Ip 60 Mg Immediate Release Tablet},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {6},
        pages = {5921-5925},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=187696},
        abstract = {Diltiazem Hydrochloride, a benzothiazepine calcium channel blocker, is widely used in the management of hypertension, angina pectoris, and cardiac arrhythmias due to its potent vasodilatory and cardiodepressant actions. The development of an Immediate Release (IR) tablet of Diltiazem HCl 60 mg requires a comprehensive understanding of its physicochemical properties, excipient compatibility, and formulation behavior to ensure rapid disintegration and optimal bioavailability. As a highly water-soluble BCS Class I drug, Diltiazem HCl lends itself well to IR formulations; however, challenges such as moisture sensitivity, poor flowability, and compression characteristics demand a carefully optimized manufacturing approach.This review critically evaluates the formulation strategies, including the selection of suitable diluents, binders, disintegrants, and lubricants, along with the influence of granulation techniques on tablet quality. It further discusses key pre-compression and post-compression parameters such as flow properties, hardness, friability, drug content, and dissolution profile that determine the overall performance of the dosage form. Emp hasis is placed on achieving rapid drug release, complying with pharmacopeial standards, and ensuring stability under ICH-recommended conditions.Overall, this article provides a detailed scientific overview of the formulation and evaluation of Diltiazem Hydrochloride IP 60 mg Immediate Release tablets, highlighting critical factors that contribute to a safe, stable, and therapeutically effective oral dosage form for cardiovascular disease management.},
        keywords = {Diltiazem Hydrochloride, Immediate Release Tablet, Calcium Channel Blocker, Tablet Formulation, Dissolution, Disintegration, Quality Evaluation, Wet Granulation.},
        month = {November},
        }